Brookdale Senior Living Inc.
NYSE:BKDMedical - Care Facilities
+$0.05 today
- Market cap
- $2.06B
- Beta
- 0.62
- P/E (TTM)
- -15.9
- EPS (TTM)
- -$0.86
Volume 4.89M
Average 3.63M
BKD EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Brookdale Senior Living Inc.NYSE: BKD
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $124.98M rose 20.6% year over year, ahead of the -8.8% change in trailing-twelve-month EBITDA. Sequentially, it rose 21.5% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.
Context
- EBITDA amounted to 11.5% of revenue in FY2025, down 3.0 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $572.42M (+59.6%) for the fiscal year ending Dec 2026, a step up from the -16.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $124.98M+21.5% QoQ
- Last fiscal yearDec 2025
- $358.72M-16.7% YoY
- LTMSep 2026
- $411.59M-8.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +20.6% | +99.0% | +78.4 pp |
| 1 year | -16.7% | +59.6% | +76.3 pp |
| 3-year CAGR | +3.9% | +18.6% | +14.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 358.72M USD
- Year-over-year change
- -16.7%
- 4-year CAGR
- -4.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 358.72M | -16.7% |
| FY2024 | 2024-12-31 | 430.53M | +14.2% |
| FY2023 | 2023-12-31 | 376.99M | +17.8% |
| FY2022 | 2022-12-31 | 319.92M | -24.8% |
| FY2021 | 2021-12-31 | 425.23M | — |
EBITDA vs competitors
How BKD compares with its peers on the latest reported figures
- BKD's LTM Sep 2026 EBITDA of $411.59M is the 2nd highest of the 10 companies compared; the peer median is -$372.36M.
- Its year-over-year change of -8.8% is the 5th highest of 10, against a peer median of -10.5%.
- EBITDA amounts to 14.0% of revenue for BKD, versus a peer median of 16.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $505.76M | -10.5% | -2.2% | 7.9% |
| LTM Sep 2026 | $411.59M | -8.8% | +3.9% | 14.0% | |
| LTM Oct 2026 | $347.65M | +31.1% | — | 13.0% | |
| LTM Sep 2026 | $207.86M | +10.1% | +46.3% | 13.1% | |
| LTM Jun 2026 | $167.37M | +23.6% | +22.7% | 11.3% | |
| LTM Jun 2026 | -$372.36M | -33.3% | — | — | |
| LTM Jun 2026 | -$419M | -48.6% | — | 358.1% | |
| LTM Jun 2026 | -$498.21M | -6.5% | — | 13823.7% | |
| LTM Sep 2026 | -$664.91M | -246.0% | — | 19.5% | |
| LTM Sep 2026 | -$1.01B | -332.3% | — | 550.8% | |
| Peer median (excluding BKD) | -$372.36M | -10.5% | +22.7% | 16.3% | |
Competitors are the stored peer set for BKD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.75B | 2.74B | 2.87B | 2.98B | 3.12B |
| Cost of Revenue | 2.26B | 2.23B | 2.12B | 2.18B | 2.48B |
| Gross Profit | 488.58M | 513.94M | 744.71M | 807.43M | 645.02M |
| Gross Margin | 17.8% | 18.7% | 26.0% | 27.1% | 20.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 359.27M | 333.89M | 384.52M | 386.63M | 349.89M |
| Operating Expenses | 705.52M | 556.63M | 726.3M | 760.9M | 627.86M |
| Depreciation & Amortization | 345.06M | 353.89M | 350.41M | 367.51M | 370.3M |
| EBITDA | 425.23M | 319.92M | 376.99M | 430.53M | 358.72M |
| EBITDA Margin | 15.5% | 11.7% | 13.1% | 14.4% | 11.5% |
| Operating Income | (216.94M) | (42.69M) | 18.41M | 46.53M | 17.17M |
| Operating Margin | -7.9% | -1.6% | 0.6% | 1.6% | 0.5% |
| Interest Income | 1.35M | 6.94M | 23.15M | 19.16M | 12.38M |
| Interest Expense | 187.69M | 205.93M | 231.72M | 243.29M | 253.11M |
| Other Income / Expenses | 109.41M | (197.21M) | (198.7M) | (243.88M) | (281.86M) |
| Income Before Tax | (107.53M) | (239.9M) | (180.29M) | (197.35M) | (264.7M) |
| Pre-Tax Margin | -3.9% | -8.7% | -6.3% | -6.6% | -8.5% |
| Income Tax Expense | (8.16M) | (1.56M) | 8.78M | 4.65M | (1.95M) |
| Net Income | (99.29M) | (238.43M) | (189.01M) | (201.94M) | (262.69M) |
| Net Margin | -3.6% | -8.7% | -6.6% | -6.8% | -8.4% |
| EPS (Basic) | (0.54) | (1.25) | (0.84) | (0.89) | (1.11) |
| EPS (Diluted) | (0.54) | (1.25) | (0.84) | (0.89) | (1.11) |
| Weighted Avg Shares | 184.98M | 190.46M | 225.21M | 227.53M | 234.33M |
| Weighted Avg Shares (Diluted) | 184.98M | 190.46M | 225.21M | 227.53M | 234.33M |
Brookdale Senior Living Inc.
NYSE:BKD
Intrinsic Alpha fair value
Locked
Current Price
$8.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.